BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20974356)

  • 1. Lymph node imaging in gynecologic malignancy.
    Lai G; Rockall AG
    Semin Ultrasound CT MR; 2010 Oct; 31(5):363-76. PubMed ID: 20974356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pearls and pitfalls of MR lymphography in gynecologic malignancy.
    Narayanan P; Iyngkaran T; Sohaib SA; Reznek RH; Rockall AG
    Radiographics; 2009; 29(4):1057-69; discussion 1069-71. PubMed ID: 19605656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance lymphography: a novel technique for lymph node assessment in gynecologic malignancies.
    Narayanan P; Iyngkaran T; Sohaib SA; Reznek RH; Rockall AG
    Cancer Biomark; 2009; 5(2):81-8. PubMed ID: 19414925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node imaging: basic principles.
    Luciani A; Itti E; Rahmouni A; Meignan M; Clement O
    Eur J Radiol; 2006 Jun; 58(3):338-44. PubMed ID: 16473489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of cervical lymph nodes in head and neck cancer: the basics.
    Gor DM; Langer JE; Loevner LA
    Radiol Clin North Am; 2006 Jan; 44(1):101-10, viii. PubMed ID: 16297684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal staging.
    Ganeshalingam S; Koh DM
    Cancer Imaging; 2009 Dec; 9(1):104-11. PubMed ID: 20080453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG positron emission tomography detection of pelvic nodal metastases in gynecologic cancer.
    Siegel BA; Adler LP; Wahl RL
    AJR Am J Roentgenol; 2002 Mar; 178(3):762-4. PubMed ID: 11856715
    [No Abstract]   [Full Text] [Related]  

  • 8. Problems and prospects of modern lymph node imaging.
    Wunderbaldinger P
    Eur J Radiol; 2006 Jun; 58(3):325-37. PubMed ID: 16464553
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
    Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
    Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
    Saksena MA; Saokar A; Harisinghani MG
    Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel imaging modalities for lymph node imaging in urologic oncology.
    Chernyak V
    Urol Clin North Am; 2011 Nov; 38(4):471-81, vii. PubMed ID: 22045178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography.
    Williams AD; Cousins C; Soutter WP; Mubashar M; Peters AM; Dina R; Fuchsel F; McIndoe GA; deSouza NM
    AJR Am J Roentgenol; 2001 Aug; 177(2):343-8. PubMed ID: 11461859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer.
    Small W; Vern TZ; Rademaker A; Nemcek A; Spies S; Schink JC; Singh DK; Lurain JR
    Am J Clin Oncol; 2010 Feb; 33(1):89-93. PubMed ID: 19730352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in lymph node imaging.
    Torabi M; Aquino SL; Harisinghani MG
    J Nucl Med; 2004 Sep; 45(9):1509-18. PubMed ID: 15347718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.
    Dalla Palma M; Gregianin M; Fiduccia P; Evangelista L; Cervino AR; Saladini G; Borgato L; Nicoletto MO; Zagonel V
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):84-98. PubMed ID: 22245509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
    Schwartz DL; Macapinlac HA; Weber RS
    J Natl Cancer Inst; 2008 May; 100(10):688-9. PubMed ID: 18477798
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathways of lymphatic spread in gynecologic malignancies.
    Paño B; Sebastià C; Ripoll E; Paredes P; Salvador R; Buñesch L; Nicolau C
    Radiographics; 2015; 35(3):916-45. PubMed ID: 25969940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.
    Kim SK; Choi HJ; Park SY; Lee HY; Seo SS; Yoo CW; Jung DC; Kang S; Cho KS
    Eur J Cancer; 2009 Aug; 45(12):2103-9. PubMed ID: 19403303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Montie JE
    J Urol; 2005 Sep; 174(3):870-1. PubMed ID: 16093977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.